Format

Send to

Choose Destination
Cancer Res. 2011 Apr 1;71(7):2411-6. doi: 10.1158/0008-5472.CAN-10-2583. Epub 2011 Mar 22.

Tumor-associated neutrophils: new targets for cancer therapy.

Author information

1
Division of Pulmonary Allergy & Critical Care Medicine, Department of Medicine, and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Abstract

Studies have begun to emerge showing critical roles for neutrophils in tumorigenesis. Neutrophils can have a significant impact on the tumor microenvironment via their production of cytokines and chemokines, which influence inflammatory cell recruitment and activation. Additionally, products secreted from neutrophils, such as reactive oxygen species and proteinases, have defined and specific roles in regulating tumor cell proliferation, angiogenesis, and metastasis. Although evidence suggests that neutrophils act in a decidedly protumor capacity in vivo, recent studies indicate that neutrophils may be manipulated to exhibit cytotoxicity against tumors. Herein, we explore the idea of targeting tumor-associated neutrophils as a means of antitumor therapy and the important ramifications such manipulation could pose to host tissues.

PMID:
21427354
DOI:
10.1158/0008-5472.CAN-10-2583
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center